Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1962 Jun;37(193):242–252. doi: 10.1136/adc.37.193.242

Wilson's Disease

C B M Warren, P M G Broughton
PMCID: PMC2012857  PMID: 14040172

Full text

PDF
242

Images in this article

243Fig. 1
on p.243
244Fig. 3
on p.244
249Fig. 9
on p.249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON P. J., POPPER H. Changes in hepatic structure in Wilson's disease. Am J Pathol. 1960 May;36:483–497. [PMC free article] [PubMed] [Google Scholar]
  2. BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
  3. BEARN A. G., KUNKEL H. G. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria. J Clin Invest. 1954 Mar;33(3):400–409. doi: 10.1172/JCI102912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BICKEL H., NEALE F. C., HALL G. A clinical and biochemical study of hepatolenticular degeneration (Wilson's disease). Q J Med. 1957 Oct;26(104):527–558. [PubMed] [Google Scholar]
  5. CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., WINTROBE M. M., BEAN W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J Clin Invest. 1954 Nov;33(11):1487–1501. doi: 10.1172/JCI103027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CARTWRIGHT G. E., MARKOWITZ H., SHIELDS G. S., WINTROBE M. M. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. Am J Med. 1960 Apr;28:555–563. doi: 10.1016/0002-9343(60)90150-9. [DOI] [PubMed] [Google Scholar]
  7. CHALMERS T. C., IBER F. L., UZMAN L. L. Hepatolenticular degeneration (Wilson's disease) as a form of idiopathic cirrhosis. N Engl J Med. 1957 Feb 7;256(6):235–242. doi: 10.1056/NEJM195702072560601. [DOI] [PubMed] [Google Scholar]
  8. ENGER E. Wilson's disease; report of a case with normal serum ceruloplasmin level. Acta Med Scand. 1959 Feb 25;163(2):121–124. [PubMed] [Google Scholar]
  9. FISTER W. P., BOULDING J. E., BAKER R. A. The treatment of hepatolenticular degeneration with penicillamine; with report of two cases. Can Med Assoc J. 1958 Jan 15;78(2):99–102. [PMC free article] [PubMed] [Google Scholar]
  10. HOLLISTER L. E., CULL V. L., GONDA V. A., KOLB F. O. Hepatolenticular degeneration. Clinical, biochemical and pathologic study of a patient with fulminant course aggravated by treatment with BAL and versenate. Am J Med. 1960 Apr;28:623–630. doi: 10.1016/0002-9343(60)90157-1. [DOI] [PubMed] [Google Scholar]
  11. LYGREN T., SORENSEN E. W. Hepatolenticular degeneration (Wilson's disease); a case diagnosed biochemically before clinical manifestations. Lancet. 1959 Feb 7;1(7067):276–277. doi: 10.1016/s0140-6736(59)90203-x. [DOI] [PubMed] [Google Scholar]
  12. MATTHEWS W. B., MILNE M. D., BELL M. The metabolic disorder in hepato-lenticular degeneration. Q J Med. 1952 Oct;21(84):425–446. [PubMed] [Google Scholar]
  13. OSBORN S. B., WALSHE J. M. Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease. Lancet. 1958 Jan 11;1(7011):70–73. doi: 10.1016/s0140-6736(58)92567-4. [DOI] [PubMed] [Google Scholar]
  14. PLAYOUST M. R., DALE N. E. Metabolic balance studies in a patient with Wilson's disease and hypercalcuria. Metabolism. 1961 Apr;10:304–314. [PubMed] [Google Scholar]
  15. RAVIN H. A. Rapid test for hepatolenticular degeneration. Lancet. 1956 May 19;270(6925):726–727. doi: 10.1016/s0140-6736(56)90751-6. [DOI] [PubMed] [Google Scholar]
  16. ROSENOER V. M., FRANGLEN G. Caeruloplasmin in Wilson's disease. Lancet. 1959 Dec 26;2(7113):1163–1164. doi: 10.1016/s0140-6736(59)91739-8. [DOI] [PubMed] [Google Scholar]
  17. SASS-KORTSAK A., CHERNIAK M., GEIGER D. W., SLATER R. J. Observations on ceruloplasmin in Wilson's disease. J Clin Invest. 1959 Oct;38:1672–1682. doi: 10.1172/JCI103945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. SCHEINBERG I. H., STERNLIEB I. The long term management of hepatolenticular degeneration (Wilson's disease). Am J Med. 1960 Aug;29:316–333. doi: 10.1016/0002-9343(60)90028-0. [DOI] [PubMed] [Google Scholar]
  19. SEVEN M. J., KLIMAN B., PETERSON R. E. Clinical studies with penicillamine in hepatolenticular degeneration. Am J Med Sci. 1959 Jan;237(1):49–58. doi: 10.1097/00000441-195901000-00007. [DOI] [PubMed] [Google Scholar]
  20. STEIN W. H., BEARN A. G., MOORE S. The amino acid content of the blood and urine in Wilson's disease. J Clin Invest. 1954 Mar;33(3):410–419. doi: 10.1172/JCI102913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Soothill J. F., Blainey J. D., Neale F. C., Fischer-Williams M., Melnick S. C. A family study of the biochemical defects in Wilson's disease. J Clin Pathol. 1961 May;14(3):264–270. doi: 10.1136/jcp.14.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. UZMAN L. L. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration. AMA Arch Pathol. 1957 Oct;64(4):464–479. [PubMed] [Google Scholar]
  23. WALSHE J. M. Disturbances of aminoacid metabolism following liver injury; a study by means of paper chromatography. Q J Med. 1953 Oct;22(88):483–505. [PubMed] [Google Scholar]
  24. WARNOCK C. G., NEILL D. W. The diagnosis and treatment of Wilson's disease. Brain. 1958 Jun;81(2):258–267. doi: 10.1093/brain/81.2.258. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES